Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Amgen

Market Cap: US$174.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Novartis

Market Cap: CHF 208.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Niagen Bioscience

Market Cap: US$520.6m

Operates as a bioscience company engages in developing healthy aging products.

Altimmune

Market Cap: US$526.9m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

Harmony Biosciences Holdings

Market Cap: US$2.2b

A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.

argenx

Market Cap: €45.0b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Camurus

Market Cap: SEK 36.1b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bausch Health Companies

Market Cap: US$2.5b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Humacyte

Market Cap: US$207.9m

Engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Regeneron Pharmaceuticals

Market Cap: US$76.8b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Krystal Biotech

Market Cap: US$6.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

NovaBay Pharmaceuticals

Market Cap: US$371.7m

Manufactures and sells wound care products.

Charlotte's Web Holdings

Market Cap: CA$44.6m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Mesoblast

Market Cap: AU$3.7b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

BioNTech

Market Cap: US$22.0b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Cassava Sciences

Market Cap: US$137.7m

A clinical stage biotechnology company, develops drugs for neurodegenerative diseases.

ACADIA Pharmaceuticals

Market Cap: US$4.5b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Hikma Pharmaceuticals

Market Cap: UK£3.3b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Genmab

Market Cap: DKK 126.8b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Elanco Animal Health

Market Cap: US$11.0b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Iovance Biotherapeutics

Market Cap: US$1.0b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

AbCellera Biologics

Market Cap: US$1.1b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Clinuvel Pharmaceuticals

Market Cap: AU$664.2m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Sarepta Therapeutics

Market Cap: US$2.1b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Exelixis

Market Cap: US$11.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

TG Therapeutics

Market Cap: US$4.4b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Corcept Therapeutics

Market Cap: US$8.6b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Organon

Market Cap: US$1.8b

Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.

Consun Pharmaceutical Group

Market Cap: HK$13.4b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

Danaher

Market Cap: US$158.5b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Invivyd

Market Cap: US$531.5m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

BeOne Medicines

Market Cap: US$34.0b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

SELLAS Life Sciences Group

Market Cap: US$333.3m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Indivior

Market Cap: US$4.4b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.